SPOTLIGHT -
New research looks at the effects of CBD on positive and negative psychotic symptoms, cognitive performance, level of functioning, and the treating psychiatrist’s overall clinical impression.
DBS: A Solution to Treatment-Resistant Schizophrenia
Treating ‘Morally Objectionable’ Patients
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Psychosis and Cannabis Use Disorder
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
The 2024 APA Annual Meeting: Tuesday, May 7
Investigators Share Baseline Data From Study on Iclepertin for Schizophrenia at APA Annual Meeting